Medical Treatment of
Chemical Warfare Casualties


MAJ Tom Garigan
Last Update: 5 April 1996


Overview:

  • Purpose
  • History
  • Nerve Agents
  • Lung Agents
  • Vesicants/Blister Agents/Lewisite
  • Vomiting Agents
  • Blood Agents
  • Incapacitating Agents
  • Riot Control Agents
  • Purpose:

    Chemical Warfare Agents Defined:

    United Nations 1969 - " ... chemical substances, whether gaseous, liquid or solid, which might be employed because of their direct toxic effects on man, animals and plants ... ".

    Toxins, i.e., poisons produced by living organisms and their synthetic equivalents:
    Are covered by the Biological and Toxin Weapons Convention of 1972.

    20th century- @ 70 different chemicals used or stockpiled as CW agents.
    Only a few of these are of practical interest:


    General Characteristics:

    *less than 1/100 of the lethal dose causes incapacitation, e.g., nausea, visual problems


    History:


    WW1- Chemical weapons caused 1.3 million casualties, 92,000 deaths


    Known to possess chemical weapons:

    US, France, Iraq

    Suspected of having chemical weapons:

    Burma, China, India, Pakistan, Egypt, Israel, Ethiopia, Kuwait, Libya, North Korea, South Korea, Thailand, Taiwan, Syria, Vietnam


    Nerve Agents (Organo-phosphorus compounds)

    History

    These are called "G" Agents (for "German")

    At the end of World War 2- Russians captured Duhernfurt facility and personnel ---> moved to Russia

    After World War 2:

    Only known hostile uses of Nerve Agents: Iraq against Iran, Kurds; Tokyo Subway

    1990- US began destroying its stockpile

    Types of Nerve Agents

    Rapid hydrolysis in alkaline solutions


    Mechanism of Action: Acetylcholinesterase inhibition


    Cholinergic Synapses:

    Step 1 ==== Reversible binding
    Step 2 ==== Irreversible binding
    Step 3 ==== Aging"- no possible reactivation by oximes

    T1/2 of Aging

    Restoration of AChE= at least two weeks

    Other possible binding of Nerve Agents

    Muscarinic Receptors & Results of Nerve Agent Action-

    Nicotinic Receptors & Results of Nerve Agent Action-

    Types of Exposures to Nerve Agents


    Low Vapor Doses

    Skin exposure
    Very low dose-

    Local effects-

    Higher dose

    High Vapor Dose

    Nerve Agents Cause Death By:

    EFFECTS OF NERVE AGENTS BY ORGAN SYSTEM

    CNS EFFECTS

    PULMONARY EFFECTS

    CARDIAC EFFECTS

    EYES

    Upon inhalation- the symptoms in order of occurrence:

    "SLUDGE"


    Medical Treatment of Nerve Agent Casualties


    Decon


    ABC's


    MARK I Kit- Q5-8 minutes

    Atropine

    Give atropine until:

    If NOT exposed to Nerve Agent:
    2 mg of Atropine------>up to 4-6 hrs of:

    2 PAM Cl or HI-6= Oximes-

    2 PAM Cl (protopam)-

    HI-6

    Valium-

    Pretreatment with p.o.?


    Observe Nerve Agent Casualties for 18+ hours
    Until free of symptoms except miosis

    OTHER MEDS:

    Pyridostigmine

    Side Effects of Pyridostigmine:

    Blood testing if needed to confirm Nerve Agent Poisoning


    Lung Agent= Phosgene (CG)

    Clinical Effects:

    Onset of Sx- 10-24 hrs

    ABG findings

    CXR findings

    Medical RX


    Vesicants/Blister Agents

    See Later Sections for:

    History


    Produced 1822; Simple to make
    Harmful effects discovered in 1860.

    First World War

    Iran-Iraq War (1979-1988)-

    Mechanism of Action:

    Alkylating Agent- reacts with proteins, nucleic acids, cell membranes
    Cells repair DNA using NAD-----> NADdepletion---->inhibited cellular glycolysis---> cell necrosis
    Mustard agent interacts with intracellular glutathion. (small peptide which takes care of the free radicals)

    Clinical Effects

    Skin-
    Biphasic response

    Itching, +/- dryness & pallor-->Erythema--> vesicles--> bullae--> necrosis and ulceration--> hyperpigmentation

    Eye-

    Lung-

    Chronic pulmonary changes:

    Upper Airway


    GI-

    Heme-

    CNS-

    Medical Treatment of Mustard Casualties:

    Decontaminate:

    M258 Kit Towelletes:

    Soap and water
    Absorption-

    Basic solutions-


    Flush
    Topical vs. Systemic Steroids---May slow healing
    Cooling skin with ice bags- to slow chemical reaction

    Treat as a burn:

    Other Rx:

    TREATMENT WITH ANTAGONISTS:

    Sodium Thiosulfate

    Mucomyst

    Vitamin E?

    Also Give Tetanus Toxoid
    Treat Ingestion:

    Treatment of Eyes:

    Respiratory:


    Testing:
    Urine: thiodiglycol (metabolite)


    Arsines

    Types

    Clinical Effects

    Medical Treatment



    Phosgene Oxime (an urticant) (CX)

    Immediate pain, then necrosis
    Eye irritation
    Lung effects- ? Like Mustard Agent?

    Treat:



    CYANIDES


    Hydrogen cyanide (AC) = gas
    Cyanogen chloride (CK)
    Zyklon B- was used in Nazi gas chambers.

    Mechanism of Action:
    Inhibits mitochondrial cytochrome oxidase- [cellular respiration]---->anaerobic metabolism

    CNS, Heart-- most sensitive

    Clinical Effects of Cyanide:

    Sequence of Signs and Symptoms:

    OR: another acronym:

    Physical Findings:

    Laboratory Findings:

    Medical Treatment:

    Oxygen potentiates these processes

    Metallic ions bind cyanide:

    Pre-Treatment: Methemoglobin-forming meds-


    Incapacitating Agents

    Types



    Riot Control Agents & Vomiting Agents

    Not recognized by US as chemical weapons

    Types:

    Potency:
    CR>CS>CN>DM

    Clinical Effects:

    Irritation of:

    Potential Complications:

    Clinical Effects of "Vomiting Agents"

    sx may take minutes to develop
    Last 20-120 minutes
    headache, chills, N/V/D, malaise
    upper resp tract sx
    rhinorrhea, salivation
    Rx= chloroform inhalation

    Medical RX-

    Do not use bleach

    Decon with water, soap

    Skin lotions
    Topical steroids
    Vesicles: topical antibiotics

    Bronchodilators
    Assisted ventilation

    Eye:



    U.S. Army Modernization Plan, May '94 ASTMP Chapter III

    c. Demonstrations Supporting System of Medical Chemical Defense

    Cyanide Pretreatment (91-99)
    Methemoglobin former= oral pretreatment
    Methemoglobin preferentially binds cyanide.
    Lead candidate compound = 8-aminoquinoline

    M291 skin decontaminating kit- activate resin mixture- black.
    1- absorbent
    2- sulfonic acid
    3- hydroxy amine
    Will train with actual kit. Non-irritating

    Topical Skin Protectant (TSP) (90-96).
    Used with MOPP Gear and the M291 skin decon kit,
    To prevent or significantly reduce the toxicity of chemical warfare agent

    Nerve Agent Antidote, Multi-Chambered Auto injector (MA) (90-97)
    Injects both through a single needle.

    New Nerve Agent Antidote System (NAAS) (91-98).
    Replaces MARK 1

    Current US Army Chemical Casualty Treatment Kit:


    Gas! Gas! Quick, boys!-- An ecstasy of fumbling,
    Fitting the clumsy helmets just in time;
    But someone still was yelling out and stumbling,
    And flound'ring like a man in fire or lime...
    Dim, through the misty panes and thick green light,
    As under a green sea, I saw him drowning.

    In all my dreams before my helpless sight,
    He plunges at me, guttering, choking, drowning,
    If in some smothering dreams you too could pace
    Behind the wagon that we flung him in,
    And watch the white eyes writhing in his face,
    His hanging face, like a devil's sick of sin;
    If you could hear, at the every jolt, the blood
    Come gargling from the froth-corrupted lungs,
    Obscene as cancer, bitter as the cud.

    Of vile incurable sores on innocent tongues,
    My friend, you would not tell with such high zest
    To children ardent for some desperate glory,
    the old Lie: Dulce et decorum est
    Pro patria mori
    ----Wilfred Owen


    Bibliography


    WWW:


    Medical Management of Chemical Casualties Course
    USAMRICD, Sept 1995 Aberdeen Proving Ground, MD
    Lecture Notes:

    Sidell, Frederick R.- Nerve Agents, Cyanide, Riot Control Agents, Incapacitating Agents
    Hurst, Charles G.- Vesicants
    Urbanetti, John S.- Phosgene


    ed. Somani, S. M. Book of Chemical Warfare Agents Academic Press, Inc 1992
    Sidell, Frederick R. Chapter 6 pp155-194
    Sidell, Frederick R. Chapter 3 "Clinical Considerations in Mustard Poisoning" pp51-66

    Smith, William J., & Dunn, Michael A. "Medical Defense Against Blistering Agents" Arch Dermatol Vol. 127 pp1207-1213

    Dunn, Michael A., & Sidell, Frederick R.; "Progress in Mdical Defense Against Nerve Agents" JAMA Vol 262:5 August 4, 1989 pp. 649-652

    Keeler, Jill R., Hurst, Charles G., Dunn, Michael A.; "Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions" JAMA Vol 266:5 August 7, 1991 pp. 693-695

    Borak, Jonathan, &Sidell, Frederick R.; "Agents of Chemical Warfare: Sulfur Mustard" Annals of Emerg Med, Vol 21:3 March 1992 pp303-308

    Sidell, Frederick R., & Borak, Jonathan; "Agents of Chemical Warfare: Sulfur Mustard" Annals of Emerg Med, Vol 21:7 July 1992 pp865-871


    Return to top of page